Opus Genetics Inc.

NASDAQ: IRD · Real-Time Price · USD
0.96
0.02 (1.90%)
At close: Jul 01, 2025, 3:59 PM
0.96
0.00%
After-hours: Jul 01, 2025, 03:59 PM EDT
1.90%
Bid 0.93
Market Cap 57.56M
Revenue (ttm) 10.99M
Net Income (ttm) -57.53M
EPS (ttm) -2.1
PE Ratio (ttm) -0.46
Forward PE -1.46
Analyst Buy
Ask 0.98
Volume 202,220
Avg. Volume (20D) 1,071,604
Open 0.92
Previous Close 0.94
Day's Range 0.92 - 0.96
52-Week Range 0.65 - 2.18
Beta 0.29

About IRD

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IRD
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for IRD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
4 weeks ago
+9.6%
Opus Genetics shares are trading higher after the ... Unlock content with Pro Subscription
6 months ago
+18.93%
Opus Genetics shares are trading higher after the company announced it secured an FDA agreement under special protocol assessment for its Phase 3 trial of Oral APX3330 in diabetic retinopathy.